Article Listing - Promising Ph III results for Biogen's Amevive

ZENITH LABS' CEFADROXIL

4 May 1992

Zenith Laboratories has received US approval for its generic cefadroxil, but an ongoing patent dispute with Bristol-Myers Squibb, which holds...

ANTIBIOTICS AND OTITIS MEDIA

4 May 1992

A meta-analysis of 10 studies has confirmed that antibiotics are effective as a short-term cure for effusive otitis media. The...

3rd HEP C VIRUS DISCOVERED

4 May 1992

Researchers at the Scottish Blood Transfusion Service, the University of Edinburgh and the Medical Research Council report discovery of a...

PAXIL, NOT AROPAX

4 May 1992

The US trade name for SmithKline Beecham's paroxetine is to be Paxil, and not Aropax. A New Drug Application for...

IG AND GUILLAIN-BARRE SYNDROME

4 May 1992

- Meantime, intravenous immunoglobulin treatment may offer a superior means of treating the Guillain-Barre syndrome, characterized by demyelinating neuropathy, than...

ORTHODOX AIDS VIEW CHALLENGED

4 May 1992

The belief that AIDS is not caused by HIV, first put forward by the scientist who mapped the genetic structure...

WORLD PHARMA MARKET PROFILE FOR 1991

4 May 1992

For 1991, the world prescription pharmaceuticals market has been valued at $174.4 million. It is a market which has shown...

LOREX' AMBIEN SET FOR US APPROVAL?

4 May 1992

Lorex Pharmaceuticals has received preliminary approval from the US Food and Drug Administration for Ambien (zolpidem tartrate) its non-benzodiazepine hypnotic...

ALLIANCE SANTE DEVELOPMENT

4 May 1992

French drug wholesaler Alliance Sante has formed a new company in a merger with Cofares of Spain, to create a...

SUCCESS IN A GLOBAL MARKETPLACE

4 May 1992

For a research-based pharmaceutical company to be successful, it needs to ensure that there is a seamless transition from the...

Showing 94041-94050 of 95329 articles